Home Cart 0 Sign in  
X

[ CAS No. 100-26-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 100-26-5
Chemical Structure| 100-26-5
Chemical Structure| 100-26-5
Structure of 100-26-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 100-26-5 ]

Related Doc. of [ 100-26-5 ]

Alternatived Products of [ 100-26-5 ]

Product Details of [ 100-26-5 ]

CAS No. :100-26-5 MDL No. :MFCD00006297
Formula : C7H5NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :LVPMIMZXDYBCDF-UHFFFAOYSA-N
M.W : 167.12 Pubchem ID :7493
Synonyms :

Calculated chemistry of [ 100-26-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 38.16
TPSA : 87.49 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.15 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.43
Log Po/w (XLOGP3) : 0.24
Log Po/w (WLOGP) : 0.48
Log Po/w (MLOGP) : -1.47
Log Po/w (SILICOS-IT) : 0.12
Consensus Log Po/w : -0.04

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.27
Solubility : 9.07 mg/ml ; 0.0543 mol/l
Class : Very soluble
Log S (Ali) : -1.64
Solubility : 3.85 mg/ml ; 0.023 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.77
Solubility : 28.7 mg/ml ; 0.172 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.46

Safety of [ 100-26-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 100-26-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 100-26-5 ]
  • Downstream synthetic route of [ 100-26-5 ]

[ 100-26-5 ] Synthesis Path-Upstream   1~38

  • 1
  • [ 589-93-5 ]
  • [ 4434-13-3 ]
  • [ 3222-47-7 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 2
  • [ 104-90-5 ]
  • [ 3222-47-7 ]
  • [ 770-08-1 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
[2] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 3
  • [ 589-93-5 ]
  • [ 4434-13-3 ]
  • [ 3222-47-7 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 4
  • [ 589-93-5 ]
  • [ 3222-47-7 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
[2] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 5
  • [ 104-90-5 ]
  • [ 3222-47-7 ]
  • [ 770-08-1 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
[2] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 6
  • [ 110-86-1 ]
  • [ 124-38-9 ]
  • [ 59-67-6 ]
  • [ 499-81-0 ]
  • [ 100-26-5 ]
  • [ 490-11-9 ]
Reference: [1] Chemical Physics, 2016, vol. 472, p. 173 - 184
  • 7
  • [ 121-34-6 ]
  • [ 100-26-5 ]
Reference: [1] Green Chemistry, 2015, vol. 17, # 11, p. 4974 - 4979
[2] Patent: US2018/148752, 2018, A1, . Location in patent: Paragraph 0182-0183; 0186-0187; 0197
  • 8
  • [ 104-90-5 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
[2] Chemische Berichte, 1888, vol. 21, p. 297
[3] Justus Liebigs Annalen der Chemie, 1888, vol. 247, p. 42
[4] Chemische Berichte, 1885, vol. 18, p. 3434
[5] Monatshefte fuer Chemie, 1913, vol. 34, p. 521
[6] Kogyo Kagaku Zasshi, 1954, vol. 57, p. 495,498[7] Chem.Abstr., 1955, p. 15892
[8] Patent: US2657207, 1951, ,
[9] Patent: DE936447, 1952, ,
[10] Memoirs of the Institute of Scientific and Industrial Research, Osaka University, 1950, vol. 7, p. 127,131[11] Chem.Abstr., 1951, p. 9054
  • 9
  • [ 140-76-1 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 10
  • [ 122-05-4 ]
  • [ 2050-89-7 ]
  • [ 100-26-5 ]
Reference: [1] Journal of Physical Chemistry B, 2001, vol. 105, # 37, p. 8838 - 8844
  • 11
  • [ 104-90-5 ]
  • [ 3222-47-7 ]
  • [ 770-08-1 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
[2] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 12
  • [ 589-93-5 ]
  • [ 4434-13-3 ]
  • [ 3222-47-7 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 13
  • [ 110-86-1 ]
  • [ 124-38-9 ]
  • [ 59-67-6 ]
  • [ 499-81-0 ]
  • [ 100-26-5 ]
  • [ 490-11-9 ]
Reference: [1] Chemical Physics, 2016, vol. 472, p. 173 - 184
  • 14
  • [ 91-63-4 ]
  • [ 100-26-5 ]
Reference: [1] Journal of the American Pharmaceutical Association (1912-1977), 1944, vol. 33, p. 223
[2] Patent: US2513099, 1947, ,
  • 15
  • [ 589-93-5 ]
  • [ 100-26-5 ]
Reference: [1] Chemische Berichte, 1904, vol. 37, p. 2063[2] Chem. Zentralbl., 1903, vol. 74, # I, p. 1034
[3] Chemische Berichte, 1887, vol. 20, p. 136
[4] Journal of the Chemical Society, 1902, vol. 81, p. 449[5] Journal of the Chemical Society, 1903, vol. 83, p. 764
[6] Monatshefte fuer Chemie, 1880, vol. 1, p. 2,41, 46
[7] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1995, vol. 31, # 1, p. 80 - 85[8] Khimiya Geterotsiklicheskikh Soedinenii, 1995, # 1, p. 90 - 96
  • 16
  • [ 589-93-5 ]
  • [ 3222-47-7 ]
  • [ 100-26-5 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
[2] Pharmaceutical Chemistry Journal, 1993, vol. 26, # 11-12, p. 894 - 896
  • 17
  • [ 104-90-5 ]
  • [ 7697-37-2 ]
  • [ 100-26-5 ]
Reference: [1] Patent: US2657207, 1951, ,
  • 18
  • [ 104-90-5 ]
  • [ 7446-08-4 ]
  • [ 7664-93-9 ]
  • [ 100-26-5 ]
Reference: [1] Memoirs of the Institute of Scientific and Industrial Research, Osaka University, 1950, vol. 7, p. 127,131[2] Chem.Abstr., 1951, p. 9054
  • 19
  • [ 91-63-4 ]
  • [ 7664-93-9 ]
  • [ 7697-37-2 ]
  • [ 100-26-5 ]
Reference: [1] Journal of the American Pharmaceutical Association (1912-1977), 1944, vol. 33, p. 223
  • 20
  • [ 91-63-4 ]
  • [ 7664-93-9 ]
  • [ 7732-18-5 ]
  • [ 7697-37-2 ]
  • [ 100-26-5 ]
Reference: [1] Patent: US2513099, 1947, ,
  • 21
  • [ 100-26-5 ]
  • [ 71-36-3 ]
  • [ 6938-06-3 ]
Reference: [1] Patent: US2861077, 1955, ,
[2] Patent: US2836601, 1956, ,
  • 22
  • [ 67-56-1 ]
  • [ 100-26-5 ]
  • [ 881-86-7 ]
YieldReaction ConditionsOperation in experiment
98%
Stage #1: With oxalyl dichloride In dichloromethane at 20℃; for 16.33 h;
Stage #2: at 0℃; for 0.25 h;
Stage #3: With sodium hydrogencarbonate In water; ethyl acetate
To a suspension of pyridine-2,5-dicarboxylic acid (20 g, 120 mmol) in dichloromethane (396 mL) and DMF (6.6 mL) was added oxalyl chloride (60.96 g, 480 mmol) dropwise over 20 minutes. After 16 hours at ambient temperature, the reaction mixture was concentrated in vacuo and the residue azeotroped with toluene. The residue was taken up in cold (00C) methanol (276 mL) and stirred for 15 minutes. The resultant solution was concentrated in vacuo and the residue taken up in ethyl acetate. The mixture was washed with a saturated aqueous solution of sodium bicarbonate, water and brine. A portion of the product was collected as a white precipitate. The organic phase was isolated, dried (Na2SO4), filtered and concentrated in vacuo to afford the title compound as a white solid (combined material obtained : 22.93 g, 98percent). LCMS (method B): Rx = 2.48 min, [M+H]+ = 196.
98% at 0 - 80℃; for 4 h; Inert atmosphere SOCl2 (28.5 mL, 0.24 mol) was added slowly to a stirred solution of compound 36 (10 g, 59.9 mmol)in methanol (100 mL) at 0 °C. After the addition, the solution was stirred at 80 °C for 4 h and thenconcentrated via rotary evaporator to get compound 37 (11.4 g, 98percent).
83%
Stage #1: for 16 h; Heating / reflux
Stage #2: With sodium hydrogencarbonate In water
Dimethyl-2,5-pyridinedicarboxylate
Dimethyl-2,5-pyridinedicarboxylate (inspired from Isagawa, K.; Kawai, M.; Fushizaki, Y. Nippon Kagaku Zasshi, 1967, 88, (5), 553-6; Dawson, M. I.; Cha, R.; Hobbs, P. D.; Chao, W-r; Schiff, L. J. J. Med. Chem., 1983, 26, 1282-1293; and Hull, K. G.; Visnick, M.; Sheffrom, A. Tetrahedron 1997, 53, 12405-12414) was prepared as described below.
2,5-pyridinedicarboxylic acid (30 g, 0.182 moles) and methanol (300 mL) were mixed together in a 1 L round bottom flask connected to a funnel containing sulfuric acid conc. (16 mL, 0.285 moles).
The acid was added dropwise over a period of 30 min, and then the funnel was removed and replaced with a condenser.
The mixture was heated at reflux for 16 h which becomes a brown and later a yellow solution.
After the reaction cooled to r.t., the slurry was poured in 500 mL of ice water.
Sodium bicarbonate solid (30 g) was added to neutralize the pH.
The reaction mixture was concentrated with evaporation in a vacuum.
The slurry was dissolved with water/chloroform and the compound processed by extraction.
The organic layer was dried with brine and then MgSO4 before solvents were evaporated under reduced pressure to yield a pale yellow solid (29.05 g, 83percent). NMR 1H 300 MHz, CDCl3 (δ, ppm): 9.29 (dd, J=1.5 Hz and 0.6 Hz, 1H, CH), 8.42 (dd, J=6 Hz and 2.1 Hz, 1H, CH), 8.19 (dd, J=7.2 Hz and 0.9 Hz, 1H, CH), 4.02 (s, 3H, CH3), 3.97 (s, 3H, CH3).
83%
Stage #1: for 16.5 h; Heating / reflux
Dimethyl-2,5-pyridinedicarboxylate.
The compound was synthesised from a procedures from Isagawa, K., et al., Nippon Kagaku Zasshi, 88(5), 553-6, 1967, Dawson, M. I., et al., J. Med. Chem. 26:1282-1293, 1983, and Hull, K. G., et al., Tetrahedron 53:12405-12414, 1997. 2,5-pyridinedicarboxylic acid (30 g, 0.182 moles) and methanol (300 mL) were mixed together in a 1 L round bottom flask connected to a funnel containing sulfuric acid conc. (16 mL, 0.285 moles).
The acid was added dropwise over a period of 30 min, and then the funnel was removed and replaced with a condenser.
The mixture was heated at reflux for 16 h which becomes a brown and later a yellow solution.
After the reaction cooled to r.t., the slurry was poured in 500 mL of ice water.
Sodium bicarbonate solid (30 g) was added to neutralize the pH.
The reaction mixture was concentrated with evaporation in a vacuum.
The slurry was dissolved with water/chloroform and the compound processed by extraction.
The organic layer was dried with brine and then MgSO4 before solvents were evaporated under reduced pressure to yield a pale yellow solid (29.05 g, 83percent). NMR 1H 300 MHz, CDCl3 (δ, ppm): 9.29 (dd, J=1.5 Hz and 0.6 Hz, 1H, CH), 8.42 (dd, J=6 Hz and 2.1 Hz, 1H, CH), 8.19 (dd, J=7.2 Hz and 0.9 Hz, 1H, CH), 4.02 (s, 3H, CH3), 3.97 (s, 3H, CH3).
78% at 0℃; for 3 h; Reflux 10311] Thionyl chloride (2.2 mE) was added dropwise to MeOH (14 mE) while stirring on ice. 2,5-Pyridinedicarbox- ylic acid (1.0 g, 6.0 mmoles) was added and the reaction heated at reflux for 3 hr. The reaction was cooled and the solvent removed under reduced pressure. The resulting residue was dissolved in DCM (15 mE), afier which saturated Na2CO3 (15 mE) was added while stirring on ice. Theaqueous layer was extracted with DCM (3x 15 mE), and the combined organics were washed with saturated Na2CO3 (2x40 mE), dried over Na2SO4(s), and concentrated under reduced pressure to afford the title compound (915 mg, 78percent) as a pale yellow solid. ‘H NMR (500 MHz, CDC13) ö 9.32 (dd, J=0.5, 2.0 Hz, 1H), 8.47 (dd, J=2.0, 8.0 Hz, 1H), 8.23 (dd, J=0.5, 8.0 Hz, 1H), 4.06 (s, 3H), 4.01 (s, 3H); ‘3C NMR (125 MHz, CDC13) ö 165.0, 164.9, 150.8, 150.8, 138.4, 128.6, 124.7, 53.3, 52.8; HRMS (ESI) mlz 196.0600 [calc’d for C9H,QNO4 (M+H) 196.0605].

Reference: [1] Patent: WO2009/85983, 2009, A1, . Location in patent: Page/Page column 65
[2] Molecules, 2014, vol. 19, # 1, p. 102 - 121
[3] European Journal of Organic Chemistry, 2013, # 3, p. 541 - 549
[4] Tetrahedron Letters, 2005, vol. 46, # 6, p. 967 - 969
[5] Patent: US2007/231300, 2007, A1, . Location in patent: Page/Page column 13-14
[6] Patent: US2008/103192, 2008, A1, . Location in patent: Page/Page column 14
[7] European Journal of Organic Chemistry, 2010, # 1, p. 174 - 182
[8] Patent: US2016/280701, 2016, A1, . Location in patent: Paragraph 0309; 0310; 0311
[9] Journal of the Chemical Society, 1902, vol. 81, p. 449[10] Journal of the Chemical Society, 1903, vol. 83, p. 764
[11] Monatshefte fuer Chemie, 1913, vol. 34, p. 521
[12] Phytochemistry (Elsevier), 1984, vol. 23, # 6, p. 1225 - 1228
[13] Tetrahedron, 2005, vol. 61, # 45, p. 10748 - 10756
[14] Journal of the American Chemical Society, 2003, vol. 125, # 1, p. 296 - 304
[15] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 9, p. 2950 - 2956
[16] RSC Advances, 2014, vol. 4, # 35, p. 18100 - 18107
[17] Patent: WO2016/109215, 2016, A1, . Location in patent: Page/Page column 58
[18] Patent: WO2018/140809, 2018, A1, . Location in patent: Paragraph 00409
  • 23
  • [ 100-26-5 ]
  • [ 881-86-7 ]
YieldReaction ConditionsOperation in experiment
98.3% With thionyl chloride In methanol for 4 h; Reflux A solution of compound 23 (10 g, 59.9 mmol)Dissolved in methanol (lOOmL)In the ice bath slowly addedTo a solution of dichlorosulfoxide (28.5 mL, 239.5 mmol)The reaction was refluxed for 4 h, Followed by spin-drying to give compound 24 (11.4 g, 98.3percent).
80% With thionyl chloride In methanol; water PREPARATION 1
dimethyl Pyridine-2,5-dicarboxylate
To a stirred slurry of 2,5-pyridinedicarboxylic acid (2407 g; 14.4 mol) in methanol (8.0 liter) at -5° to -10°C, thionylchloride (3430 g; 2.10 liters; 28.8 mol) was added dropwise while maintaining the temperature in the -5° to -10°C range.
After completing the addition, the reaction was allowed to warm to ambient temperature, and stirred for 18 hours.
The resulting solution was concentrated in vacuo to a volume of 4 liters, and an equal volume of water was added.
The PH of the well-stirred mixture was then adjusted to 10 with saturated aqueous sodium carbonate.
Solids were removed by filtration.
The organic layer of the filtrate was separated, washed with water (8 liters), and dried in vacuo to afford the title compound (2250 g; 80percent yield) as an amorphous solid.
80% With thionyl chloride In methanol; water PREPARATION 1
Dimethyl Pyridine-2,5-dicarboxylate
To a stirred slurry of 2,5-pyridinedicarboxylic acid (2407 g; 14.4 mol) in methanol (8.0 liter) at -5° to -10° C. thionylchloride (3430 g; 2.10 liters; 28 8 mol) was added dropwise while maintaining the temperature in the -5° to -10° C. range.
After completing the addition, the reaction was allowed to warm to ambient temperature, and stirred for 18 hours.
The resulting solution was concentrated in vacuo to a volume of 4 liters, and an equal volume of water was added.
The pH of the well-stirred mixture was then adjusted to 10 with saturated aqueous sodium carbonate.
Solids were removed by filtration.
The organic layer of the filtrate was separated, washed with water (8 liters), and dried in vacuo to afford the title compound (2250 g; 80percent yield) as an amorphous solid.
80% With thionyl chloride In methanol; water PREPARATION 1
Dimethyl Pyridine-2,5-dicarboxylate
To a stirred slurry of 2,5-pyridinedicarboxylic acid (2407 g; 14.4 mol) in methanol (8.0 liter) at -5° to -10° C., thionylchloride (3430 g; 2.10 liters; 28.8 mol) was added dropwise while maintaining the temperature in the -5° to -10° C. range.
After completing the addition, the reaction was allowed to warm to ambient temperature, and stirred for 18 hours.
The resulting solution was concentrated in vacuo to a volume of 4 liters, and an equal volume of water was added.
The pH of the well-stirred mixture was then adjusted to 10 with saturated aqueous sodium carbonate.
Solids were removed by filtration.
The organic layer of the filtrate was separated, washed with water (8 liters), and dried in vacuo to afford the title compound (2250 g; 80percent yield) as an amorphous solid.

Reference: [1] Patent: CN104418811, 2017, B, . Location in patent: Paragraph 0234-0236
[2] Patent: EP536173, 1995, B1,
[3] Patent: US5616585, 1997, A,
[4] Patent: US5122525, 1992, A,
  • 24
  • [ 67-56-1 ]
  • [ 100-26-5 ]
  • [ 881-86-7 ]
  • [ 17874-76-9 ]
Reference: [1] Journal of the American Chemical Society, 2005, vol. 127, # 34, p. 11914 - 11915
  • 25
  • [ 100-26-5 ]
  • [ 64-17-5 ]
  • [ 5552-44-3 ]
YieldReaction ConditionsOperation in experiment
75% for 18 h; Reflux Concentrated sulfuric acid (3.9 mL, 71.6 mmol) was added dropwise over 15 minutes to a stirred suspension of 2,5-pyridinedicarboxylic acid (3.0 g, 17.9 mol) in absolute ethanol (10 mL) and the resulting mixture heated to reflux for 18 hours. The solution was allowed to cool to room temperature and the solvents evaporated under reduced pressure. Saturated NaHCC>3 solution was added to the residue to adjust the pH to -8 then the aqueous phase was extracted with EtOAc (4 x 50 mL). The combined organic extracts were washed with brine (30 mL), dried (Na2S04) and evaporated under reduced pressure to leave the title compound (3.0 g, 75percent) which was used without further purification.
67% for 4 h; Reflux Diethyl pyridine-2,5-dicarboxylate (5.3)Pyridine-2,5-dicarboxylic acid (20.0 g, 120 mmol) was dissolved in ethanol (200 mL) and treated with concentrated solution of sulfuric acid (2.0 mL, 36 mmol) in ethanol (20 mL). The reaction was heated under reflux for 4hrs, concentrated and dissolved in EtOAc (10 mL). The mixture was washed with water (50mL), brine (50 mL), dried over sodium sulfate, filtered and evapourated to afford diethyl pyridine-2,5-dicarboxylate (18 g, 67 percent). 1 H NMR (400MHz CDCI3) δΗ ppm 1 .25 (t, 3H), 4.3 (q, 2H), 8.2 (d, 1 H), 8.4 (d, 1 H), 9.4 (s, 1 H).
26.61 g With sulfuric acid In water at 78℃; for 58 h; (0201) 2,5-pyridinedicarboxylic acid (25.08 g; 150 mmol) was added to ethanol (1,800 mL). Aqueous sulfuric acid (1.32 g) was added. The mixture was heated at reflux (about 78° C.) for 58 hours, during which time water was removed from the reaction. The reaction progress was monitored using NMR spectroscopy. After the 2,5-diethyl-2,5-pyridinedicarboxylate had been formed in >97percent purity by NMR, the reaction mixture was allowed to cool to ambient temperature and was extracted with 2-methyltetrahydrofuran. The combined organic layers were washed with a saturated aqueous brine solution and deionised water, and dried (MgSO4). The organics were filtered and the volatiles were removed in vacuo to afford the title compound (26.61 g; 120 mmol; >99percent conversion by GC).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 24, p. 3025 - 3028
[2] Journal of Porphyrins and Phthalocyanines, 2010, vol. 14, # 6, p. 469 - 480
[3] Dalton Transactions, 2015, vol. 44, # 35, p. 15391 - 15395
[4] European Journal of Organic Chemistry, 2010, # 1, p. 174 - 182
[5] CrystEngComm, 2011, vol. 13, # 8, p. 2915 - 2922
[6] Patent: WO2018/197714, 2018, A1, . Location in patent: Page/Page column 115; 116
[7] Liebigs Annalen der Chemie, 1981, # 12, p. 2164 - 2179
[8] Journal of Medicinal Chemistry, 1983, vol. 26, # 9, p. 1282 - 1293
[9] Patent: WO2013/72903, 2013, A1, . Location in patent: Page/Page column 67
[10] Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1959, vol. 32, p. 2820; engl. Ausg. S. 2904
[11] European Journal of Medicinal Chemistry, 2004, vol. 39, # 10, p. 889 - 895
[12] Angewandte Chemie - International Edition, 2015, vol. 54, # 48, p. 14570 - 14574[13] Angew. Chem., 2015,
[14] Patent: US5350772, 1994, A,
[15] Patent: US2018/148752, 2018, A1, . Location in patent: Paragraph 0200-0201
  • 26
  • [ 100-26-5 ]
  • [ 5552-44-3 ]
Reference: [1] Arhiv za Kemiju, 1946, vol. 18, p. 3,6[2] Chem.Abstr., 1948, p. 3398
[3] Kobunshi Kagaku, 1958, vol. 15, p. 839,844[4] Chem.Abstr., 1960, p. 22636
[5] Synthesis, 1999, # 4, p. 597 - 602
  • 27
  • [ 100-26-5 ]
  • [ 39977-41-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1983, vol. 26, # 9, p. 1282 - 1293
  • 28
  • [ 100-26-5 ]
  • [ 10165-86-3 ]
Reference: [1] Molecules, 2014, vol. 19, # 1, p. 102 - 121
[2] Patent: US2016/280701, 2016, A1,
[3] Patent: CN104418811, 2017, B,
  • 29
  • [ 100-26-5 ]
  • [ 56026-36-9 ]
Reference: [1] Molecules, 2014, vol. 19, # 1, p. 102 - 121
[2] Patent: WO2016/109215, 2016, A1,
[3] Patent: CN104418811, 2017, B,
[4] Patent: WO2018/140809, 2018, A1,
  • 30
  • [ 67-56-1 ]
  • [ 100-26-5 ]
  • [ 17874-76-9 ]
YieldReaction ConditionsOperation in experiment
42% for 2 h; Reflux Progress toward analog 18 has been made as follows. 2,5- Pyridinedicarboxylic acid (58) was preferentially esterified according to literature protocols66 by reflux in methanol with catalytic sulfuric acid for 2 hours to the mono- methyl ester (59) in 42percent recovered yield after recrystallization from water. The monomethyl ester 59 was refluxed in excess thionyl chloride to effect its conversion to the acid chloride (60), and 60 was used to acylate 35 by reflux in DCM with excess aluminum trichloride (Scheme 10).
33% for 2 h; Heating / reflux EXAMPLE 83a
Pyridine-2,5-dicarboxylic acid-2-methyl ester
To a suspension of pyridine-2,5-dicarboxylic acid (4.2 g, 25.1 mmol) (Aldrich) in methanol (50 mL) was added concentrated sulfuric acid (1.5 g, 15.3 mmol) (Aldrich).
The mixture was heated at refluxing for 2 hours.
The crude was cooled down to room temperature and poured into water (250 mL).
The precipitate formed was collected and washed with methanol to give pyridine-2,5-dicarboxylic acid-2-methyl ester as a grey solid. (Yield 1.5 g, 33percent).
Reference: [1] Patent: WO2011/103321, 2011, A1, . Location in patent: Page/Page column 23
[2] Patent: US2006/293319, 2006, A1, . Location in patent: Page/Page column 47
[3] Patent: WO2007/70173, 2007, A2, . Location in patent: Page/Page column 145-146
[4] European Journal of Inorganic Chemistry, 2010, # 13, p. 1913 - 1928
[5] Patent: WO2012/121973, 2012, A1, . Location in patent: Page/Page column 89
[6] Patent: WO2008/156715, 2008, A1, . Location in patent: Page/Page column 66
[7] Angewandte Chemie - International Edition, 2018, vol. 57, # 22, p. 6572 - 6576[8] Angew. Chem., 2018, vol. 130, p. 6682 - 6686,5
  • 31
  • [ 100-26-5 ]
  • [ 17874-76-9 ]
Reference: [1] Patent: US4273779, 1981, A,
  • 32
  • [ 100-26-5 ]
  • [ 7664-93-9 ]
  • [ 17874-76-9 ]
Reference: [1] Patent: US6479519, 2002, B1,
  • 33
  • [ 67-56-1 ]
  • [ 100-26-5 ]
  • [ 881-86-7 ]
  • [ 17874-76-9 ]
Reference: [1] Journal of the American Chemical Society, 2005, vol. 127, # 34, p. 11914 - 11915
  • 34
  • [ 100-26-5 ]
  • [ 17874-79-2 ]
Reference: [1] Journal of the American Chemical Society, 2005, vol. 127, # 34, p. 11914 - 11915
[2] Tetrahedron, 2005, vol. 61, # 45, p. 10748 - 10756
[3] Tetrahedron Letters, 2005, vol. 46, # 6, p. 967 - 969
[4] Patent: US2016/280701, 2016, A1,
[5] Patent: US2008/103192, 2008, A1,
  • 35
  • [ 100-26-5 ]
  • [ 50501-35-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1983, vol. 26, # 9, p. 1282 - 1293
[2] Patent: US2008/103192, 2008, A1,
  • 36
  • [ 100-26-5 ]
  • [ 106014-21-5 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 1, p. 3 - 5
  • 37
  • [ 100-26-5 ]
  • [ 323578-38-7 ]
Reference: [1] European Journal of Inorganic Chemistry, 2010, # 13, p. 1913 - 1928
  • 38
  • [ 100-26-5 ]
  • [ 337904-92-4 ]
YieldReaction ConditionsOperation in experiment
45.9% With sodium hydroxide; triethylamine In <i>tert</i>-butyl alcohol (A)
5-[(tert-Butoxycarbonyl)amino]nicotinic acid
5-Pyridinedicarboxylic acid (5.00 g, 29.9 mmol) was suspended in t-butanol (35 ml), and the solution was added dropwise with triethylamine (8.34 ml, 59.8 mmol) and diphenylphosphoric acid azide (7.10 ml, 32.9 mmol), and heated under reflux for 3 hours.
The reaction mixture was adjusted to a pH lower than 10 by addition of 1 N aqueous sodium hydroxide under ice cooling, and then washed with ether.
The reaction mixture was again cooled with ice, and adjusted to about pH 4 with 1 N aqueous sodium hydroxide.
The deposited solids were collected by filtration, and washed with water and ether to obtain the title compound as white powder (3.27 g, 45.9percent).
1H-NMR (DMSO-d6) δ: 1.49 (9H, s), 8.45 (1H, s), 8.66 (1H, s), 8.75 (1H, s), 9.83 (1H, br)
Reference: [1] Patent: EP1227084, 2002, A1,
Same Skeleton Products
Historical Records